A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization
Article in Scientific Reports (September 2023)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss
Article in Journal of Inflammation Research (February 2023)
Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor
Article in Nature Communications (June 2022)